Mitoquinone mitigates paraquat‐induced A549 lung epithelial cell injury by promoting MFN1/MFN2‐mediated mitochondrial fusion. Issue 9 (9th June 2022)

• Record Type: Journal Article
• Authors: Liu, Chao; Sun, Zhaorui; Wang, Mengmeng; Yang, Zhizhou; Zhang, Wei; Ren, Yi; Han, Xiaoqin; Zhang, Bo; Yao, Mengya; Nie, Shinan
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 36:Issue 9(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-06-09
• Subjects: A549 cells -- lung injury -- mitochondrial fusion -- mitoquinone -- paraquat; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.23127
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: Paraquat (PQ) poisoning often leads to severe lung injuries, in which the mitochondria damage plays a critical role. Mitoquinone (MitoQ), a newly designed mitochondria‐targeted antioxidant, has been proved for its benefit in mitochondria protection. However, the role of MitoQ in PQ‐induced lung injury remains unclear. Thus, this study was performed to investigate the effect of MitoQ on PQ‐induced lung injury and its underlying mechanisms. Our work showed that PQ caused the inhibition of A549 lung epithelial cell viability in a dose‐dependent manner, while MitoQ remarkably mitigated the PQ‐induced cell viability suppression. Besides this, PQ‐mediated apoptosis of A549 cells was significantly attenuated by MitoQ, as indicated by the TUNEL assay and mitochondria membrane potential assay. Moreover, the intracellular reactive oxygen species (ROS) production was also dramatically suppressed when cotreated MitoQ with PQ. This could be ascribed to enhanced mitochondrial fusion mediated by Mitofusin 1 (MFN1)/Mitofusin 2 (MFN2), because MitoQ preserved mitochondrial network integrity, as reflected by MitoTracker staining, and MitoQ also increased the expression of MFN1/MFN2 in A549 cells after PQ treatment. Our data suggested MitoQ mitigated PQ‐induced lung epithelial cell injury by promoting MFN1/MFN2‐mediated mitochondrial fusion, and MitoQ might be a potential candidate drug for the treatment of PQ‐induced lung injury.